PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.01%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-11.96%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-28.68%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-28.68%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
404.65%
Positive net income growth while BIDU is negative. John Neff might see a big relative performance advantage.
200.00%
Positive EPS growth while BIDU is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
200.00%
Positive diluted EPS growth while BIDU is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-6.94%
Share reduction while BIDU is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.28%
Reduced diluted shares while BIDU is at 0.02%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
5.58%
Positive OCF growth while BIDU is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-18.84%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
97.83%
10Y revenue/share CAGR under 50% of BIDU's 17051.48%. Michael Burry would suspect a lasting competitive disadvantage.
97.83%
5Y revenue/share CAGR under 50% of BIDU's 915.53%. Michael Burry would suspect a significant competitive gap or product weakness.
97.83%
3Y revenue/share CAGR under 50% of BIDU's 358.62%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
106.71%
OCF/share CAGR of 106.71% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
106.71%
OCF/share CAGR of 106.71% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
106.71%
3Y OCF/share CAGR of 106.71% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
-7.63%
Negative 10Y net income/share CAGR while BIDU is at 26932.90%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-7.63%
Negative 5Y net income/share CAGR while BIDU is 1261.89%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-7.63%
Negative 3Y CAGR while BIDU is 322.66%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.34%
Firm’s AR is declining while BIDU shows 3.26%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
0.40%
Asset growth well under 50% of BIDU's 4.75%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
8.08%
Similar to BIDU's 8.52%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-4.16%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-1.35%
Our R&D shrinks while BIDU invests at 15.55%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
3.27%
SG&A declining or stable vs. BIDU's 7.03%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.